이연제약
102460KOSPI의약품 제조업39.8 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
Il Yeon Pharm is a specialized pharmaceutical company established in 1964, focusing on the manufacturing and sales of prescription drugs, original pharmaceuticals (e.g., CT contrast agent 'Optirey'), and bulk drugs. Its Chungju facility, certified for biopharmaceutical production and CMO services, supports new drug pipeline development through a production-platform-based R&D model. However, as of 2024, the company reported sales of 145.9 billion won, an operating loss of 30.3 billion won, and a net loss of 29.6 billion won, indicating the need for improved profitability.
Number of Employees
457people
Average Salary
76.4M KRW
Score Calculation Basis
Detailed Financial Score
In line with industry avg
Well below industry avg
3.7x industry avg (risky)
Avg ▼1.7% (2-year basis)
Avg ▼19193.7% (2-year basis)
Avg ROE -3.2% (declining, 3yr)
Detailed News Sentiment
- Positive이연제약, 캐시카우 추가한다…3000억 지혈제 시장 공략 본격화
이연제약이 지혈제 시장에서 트롬빈 사업을 확대하여 새로운 수익원을 확보할 것으로 예상되며, 이는 회사의 성장에 긍정적 영향을 미칠 것입니다.
- Positive이연제약 "케미컬 이익창출능력+신약 성장성…바이오 도약 원년"
이연제약의 유전자치료제 NG101 임상 데이터 공개로 인해 경쟁력 강화 및 신약 성장 기대감 증가.
- Neutral
Detailed Momentum
Near 52w low (5%, downtrend)
1m -10.94% (falling)
Volume decreasing
Detailed Disclosure
- Neutral기업지배구조보고서공시2026-06-01
- Neutral분기보고서 (2026.03)2026-05-15
